Fundraising FoxSTENTIT
Netherlands, NL · 2 known investors
Find your way into STENTIT
Sign up to see every warm intro you have to STENTIT
- Paths you didn't know you had: your email and LinkedIn already hold routes to the STENTIT team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
STENTiT is a Dutch medtech company developing the Resorbable Fibrillated Scaffold (RFS), a device designed to trigger natural healing and reconstruct arteries for treating vascular conditions. The technology initially targets below-the-knee chronic limb threatening ischemia and has broader applications across endovascular treatments.
Founders & leadership
Investors · 2
Frequently asked questions
- What does STENTIT do?
- STENTiT is a Dutch medtech company developing the Resorbable Fibrillated Scaffold (RFS), a device designed to trigger natural healing and reconstruct arteries for treating vascular conditions. The technology initially targets below-the-knee chronic limb threatening ischemia and has broader applications across endovascular treatments.
- Who founded STENTIT?
- STENTIT was founded by Bart Sanders.
- Who are STENTIT's investors?
- STENTIT's investors include BOM, NextGen Ventures.
- Where is STENTIT headquartered?
- STENTIT is headquartered in Netherlands, NL.